Rivaroxaban plasma levels in patients admitted for bleeding events: insights from a prospective study

BACKGROUND: Serious bleeding events have been frequently described in patients taking direct oral anticoagulants (DOAC). In secondary analyses of phase 3 trials, DOAC plasma concentrations were shown to correlate with bleeding outcomes. This study aimed to describe rivaroxaban plasma levels in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Sennesael, Anne-Laure, Larock, Anne-Sophie, Douxfils, Jonathan, Elens, Laure, Stillemans, Gabriel, Wiesen, Martin, Taubert, Max, Dogné, Jean-Michel, Spinewine, Anne, Mullier, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231259/
https://www.ncbi.nlm.nih.gov/pubmed/30455596
http://dx.doi.org/10.1186/s12959-018-0183-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6231259/
https://www.ncbi.nlm.nih.gov/pubmed/30455596
http://dx.doi.org/10.1186/s12959-018-0183-3

Ejemplares similares